PT  - JOURNAL ARTICLE
AU  - Lavalley, Claire A.
AU  - Mehta, Marishka M.
AU  - Taylor, Samuel
AU  - Chuning, Anne E.
AU  - Stewart, Jennifer L.
AU  - Huys, Quentin J. M.
AU  - Khalsa, Sahib S.
AU  - Paulus, Martin P.
AU  - Smith, Ryan
TI  - Computational Mechanisms Underlying Multi-Step Planning Deficits in Methamphetamine Use Disorder
AID  - 10.1101/2024.06.27.24309581
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.06.27.24309581
4099  - http://medrxiv.org/content/early/2024/06/28/2024.06.27.24309581.short
4100  - http://medrxiv.org/content/early/2024/06/28/2024.06.27.24309581.full
AB  - Current theories suggest individuals with methamphetamine use disorder (iMUDs) have difficulty considering long-term outcomes in decision-making, which could contribute to risk of relapse. Aversive interoceptive states (e.g., stress, withdrawal) are also known to increase this risk. The present study analyzed computational mechanisms of planning in iMUDs, and examined the potential impact of an aversive interoceptive state induction. A group of 40 iMUDs and 49 healthy participants completed two runs of a multi-step planning task, with and without an anxiogenic breathing resistance manipulation. Computational modeling revealed that iMUDs had selective difficulty identifying the best overall plan when this required enduring negative short-term outcomes – a mechanism referred to as aversive pruning. Increases in reported craving before and after the induction also predicted greater aversive pruning in iMUDs. These results highlight a novel mechanism that could promote poor choice in recovering iMUDs and create vulnerability to relapse.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the National Institute of General Medical Sciences (grant award P20GM121312; RS and MPP), the National Institute on Drug Abuse (grant award R01DA050677; JLS) and the Laureate Institute for Brain Research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:WCG Institutional Review Board of the Laureate Institute for Brain Research gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.